Cargando…
Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease
Recently approved therapies have contributed to a significant progress in the management of ovarian cancer; yet, more options are needed to further improve outcomes in patients with advanced disease. Here we review the rationale and ongoing clinical trials of novel combination strategies involving c...
Autores principales: | Arend, Rebecca C., Jackson-Fisher, Amy, Jacobs, Ira A., Chou, Jeffrey, Monk, Bradley J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928025/ https://www.ncbi.nlm.nih.gov/pubmed/33427569 http://dx.doi.org/10.1080/15384047.2020.1868937 |
Ejemplares similares
-
Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer
por: Wall, Jaclyn A., et al.
Publicado: (2020) -
Ovarian Cancer: Current Treatment and Patient Management
por: Monk, Bradley J., et al.
Publicado: (2016) -
Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer
por: Roane, Brandon M., et al.
Publicado: (2019) -
The role of immune checkpoint inhibition in the treatment of ovarian cancer
por: Gaillard, Stéphanie L., et al.
Publicado: (2016) -
Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?
por: Herzog, Thomas J., et al.
Publicado: (2017)